Earkart completes USFDA registration, eyes global hearing healthcare market
SENSEX 83,021.75 + 989.94 NIFTY 25,514.30 + 286.35 CRUDEOIL 7,877.00 + 183.00 GOLD 127,491.00 -2,323.00 SILVER 157,691.00 -3,043.00 SENSEX 83,021.75 + 989.94 NIFTY 25,514.30 + 286.35 NIFTY 25,514.30 + 286.35 CRUDEOIL 7…

+ 989.94
NIFTY 25,514.30+ 286.35
CRUDEOIL 7,877.00+ 183.00
GOLD 127,491.00-2,323.00
SILVER 157,691.00-3,043.00
SENSEX 83,021.75+ 989.94
NIFTY 25,514.30+ 286.35
NIFTY 25,514.30+ 286.35
CRUDEOIL 7,877.00+ 183.00
CRUDEOIL 7,877.00+ 183.00
GOLD 127,491.00-2,323.00
'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.The US hearing aids market is estimated to grow from $4.65 billion in 2026 to $9.57 billion by 2035 at an annual growth rate of 8.4%, according to Emergen Research
By PTI
Updated - November 20, 2026 at 07:46 AM. | New DelhiEarkart aims to offer its branded hearing aids to US consumers at affordable prices, company says.
Earkart has completed its US Food and Drug Administration (FDA) establishment registration and secured active medical device listings across four hearing aid categories, marking a step towards its international expansion.
The company's portfolio covers prescription, wireless prescription and wireless OTC (over-the-counter) hearing aids, according to a company statement.
It aims to offer its branded hearing aids to US consumers at affordable prices, the company added.
Earkart, a hearing healthcare technology company, plans to explore partnerships, distribution opportunities and market-entry strategies in the US, leveraging its indigenous product development and manufacturing capabilities.
The US hearing aids market is estimated to grow from $4.65 billion in 2026 to $9.57 billion by 2035 at an annual growth rate of 8.4 per cent, according to Emergen Research.
"Completing our US FDA establishment registration and securing active device listings across four hearing aid categories is an important milestone in Earkart's international growth journey," the company said.
Published on November 20, 2026
THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!- Access 10 free stories per month
- Get notified by email for early preview to new features, discounts & offers
Figures reflect the source report and its stated period. This article is for information and is not investment advice.



